Would you offer local therapy with either SBRT or Y-90 in a patient with metastatic ER+ HER2 low breast cancer with two oligometastatic liver lesions currently on AI + CDK4/6 inhibitor?
Answer from: Medical Oncologist at Community Practice
No.Longer answer:I acknowledge that controlling liver disease improves outcomes in metastatic cancer (including breast, and including y-90 for breast Barakat et al., PMID 35071835). However, it depends on how and when you use the tool. My reason for saying no in this setting: this is a patient with ...
Comments
Medical Oncologist at Indiana University School of Medicine No.
Much shorter long answer...we've studied loca...
No. Much shorter long answer...we've studied loca...